Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ziprasidone' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 37 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Green, B
      Focus on ziprasidone

      CURRENT MEDICAL RESEARCH AND OPINION
    2. Canas, F
      Sustaining short-term gains for future progress

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    3. Casey, DE
      Barriers to progress - the impact of tolerability problems

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    4. Mansbach, RS; Carver, J; Zorn, SH
      Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    5. Bymaster, FP; Falcone, JF; Bauzon, D; Kennedy, JS; Schenck, K; DeLapp, NW; Cohen, ML
      Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. Schmidt, AW; Lebel, LA; Howard, HR; Zorn, SH
      Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Daniel, DG; Potkin, SG; Reeves, KR; Swift, RH; Harrigan, EP
      Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

      PSYCHOPHARMACOLOGY
    8. Kamel, A; Prakash, C; Saverino, C; Obach, B; Fouda, H
      Narrow-bore high-performance liquid chromatography in combination with ionspray tandem mass spectrometry for the determination of the substance P receptor antagonist ezlopitant and its two active metabolites in plasma

      JOURNAL OF CHROMATOGRAPHY B
    9. Daniel, DG; Copeland, LF
      Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Sallee, FR; Kurlan, R; Goetz, CG; Singer, H; Scahill, L; Law, G; Dittman, VM; Chappell, PB
      Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    11. Balestrieri, M; Vampini, C; Bellantuono, C
      Efficacy and safety of novel antipsychotics: A critical review

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    12. Brook, S
      A pilot study of intramuscular ziprasidone in the short-term treatment of patients with acute exacerbation of schizophrenia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    13. Miceli, JJ; Wilner, KD; Hansen, RA; Johnson, AC; Apseloff, G; Gerber, N
      Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    14. Wilner, KD; Tensfeldt, TG; Baris, B; Smolarek, TA; Turncliff, RZ; Colburn, WA; Hansen, RA
      Single- and multiple-dose pharmacokinetics of ziprasidone in healthy youngand elderly volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    15. Everson, G; Lasseter, KC; Anderson, KE; Bauer, LA; Carithens, RL; Wilner, KD; Johnson, A; Anziano, RJ; Smolarek, TA; Turncliff, RZ
      The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    16. Aweeka, F; Jayesekara, D; Horton, M; Swan, S; Lambrecht, L; Wilner, KD; Sherwood, J; Anziano, RJ; Smolarek, TA; Turncliff, RZ
      The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    17. Prakash, C; Kamel, A; Cui, D; Whalen, RD; Miceli, JJ; Tweedie, D
      Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    18. Wilner, KD; Demattos, SB; Anziano, RJ; Apseloff, G; Gerber, N
      Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    19. Muirhead, GJ; Harness, J; Holt, PR; Oliver, S; Anziano, RJ
      Ziprasidone and the pharmacokinetics of a combined oral contraceptive

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    20. Wilner, KD; Hansen, RA; Folger, CJ; Geoffroy, P
      The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    21. Apseloff, G; Mullet, D; Wilner, KD; Anziano, RJ; Tensfeldt, TG; Pelletier, SM; Gerber, N
      The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    22. Miceli, JJ; Anziano, RJ; Robarge, L; Hansen, RA; Laurent, A
      The effect of carbamazepine on the steady state pharmacokinetics of ziprasidone in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    23. Miceli, JJ; Smith, M; Robarge, L; Morse, T; Laurent, A
      The effects of ketoconazole on ziprasidone pharmacokinetics - a placebo-controlled crossover study in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    24. Peuskens, J
      Switching approach in the management of schizophrenia patients

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    25. Keltner, NL; Coffeen, H; Johnson, JE
      Atypical antipsychotic drugs: Part II

      PERSPECTIVES IN PSYCHIATRIC CARE
    26. Taylor, DM; McAskill, R
      Atypical antipsychotics and weight gain - a systematic review

      ACTA PSYCHIATRICA SCANDINAVICA
    27. Duncan, GE; Zorn, S; Lieberman, JA
      Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

      MOLECULAR PSYCHIATRY
    28. Kendrick, T
      The newer, 'atypical' antipsychotic drugs - their development and current therapeutic use

      BRITISH JOURNAL OF GENERAL PRACTICE
    29. Keck, PE; McElroy, SL; Strakowski, SM
      Schizoaffective disorder: role of atypical antipsychotics

      SCHIZOPHRENIA RESEARCH
    30. Daniel, DG; Zimbroff, DL; Potkin, SG; Reeves, KR; Harrigan, EP; Lakshminarayanan, M
      Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial

      NEUROPSYCHOPHARMACOLOGY
    31. Dawkins, K; Lieberman, JA; Lebowitz, BD; Hsiao, JK
      Antipsychotics: Past and future - National Institute of Mental Health Division of Services and Intervention Research Workshop, July 14, 1998

      SCHIZOPHRENIA BULLETIN
    32. Zhang, W; Bymaster, FP
      The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D-1, D-2, D-3, 5HT(2A) and muscarinic receptors

      PSYCHOPHARMACOLOGY
    33. NEWMANTANCREDI A; GAVAUDAN S; CONTE C; CHAPUT C; TOUZARD M; VERRIELE L; AUDINOT V; MILLAN MJ
      AGONIST AND ANTAGONIST ACTIONS OF ANTIPSYCHOTIC AGENTS AT 5-HT1A RECEPTORS - A [S-35] GTP-GAMMA-S BINDING STUDY

      European journal of pharmacology
    34. KECK P; BUFFENSTEIN A; FERGUSON J; FEIGHNER J; JAFFE W; HARRIGAN EP; MORRISSEY MR
      ZIPRASIDONE 40 AND 120 MG DAY IN THE ACUTE EXACERBATION OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER - A 4-WEEK PLACEBO-CONTROLLED TRIAL/

      Psychopharmacology
    35. SKARSFELDT T
      DIFFERENTIAL EFFECT OF ANTIPSYCHOTICS ON PLACE NAVIGATION OF RATS IN THE MORRIS WATER MAZE - A COMPARATIVE-STUDY BETWEEN NOVEL AND REFERENCE ANTIPSYCHOTICS

      Psychopharmacology
    36. BENCH CJ; LAMMERTSMA AA; GRASBY PM; DOLAN RJ; WARRINGTON SJ; BOYCE M; GUNN KP; BRANNICK LY; FRACKOWIAK RSJ
      THE TIME-COURSE OF BINDING TO STRIATAL DOPAMINE D-2 RECEPTORS BY THE NEUROLEPTIC ZIPRASIDONE (CP-88,059-01) DETERMINED BY POSITRON EMISSIONTOMOGRAPHY

      Psychopharmacology
    37. SKARSFELDT T
      DIFFERENTIAL-EFFECTS OF REPEATED ADMINISTRATION OF NOVEL ANTIPSYCHOTIC-DRUGS ON THE ACTIVITY OF MIDBRAIN DOPAMINE NEURONS IN THE RAT

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:38:49